One explanation could be that the absolute Alzheimer’s disease risk of APOE ε4 carriers is so pronounced that the additional presence or absence of a weaker risk factor, such as inflammation, may not have much impact. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.